News
Eczema now joins the list of inflammatory conditions linked to cardiovascular risk.
British researchers report that i…
Glenmark Pharmaceuticals shared data from a Phase 2a, proof-of-concept study of GBR 830, an investigational, anti-OX40 m…
DUPIXENT (dupilumab) performed well in a Phase 3 Trial of inadequately controlled moderate-to-severe atopic dermati…
A new clinical trial is investigating whether beneficial bacteria can help treat eczema by restoring the natural microbi…
Emollient bath additives provide no meaningful benefit when used in addition to standard eczema care in children, accord…
Kudos to the Skin of Color Society (SOCS) for a banner year.
At its recent annual business meeting held in conjunctio…
Israeli-based Kamedis announced the formation of a U.S. medical advisory board.
The members include:
Zoe Draelos, …
Perhaps no surprise to dermatologists, new research reveals that one-third of YouTube videos about atopic dermatitis con…
Top 5 In Atopic Dermatitis